A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

NCT01302054 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

990

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Bladder, Overactive

Interventions

DRUG: Fesoterodine 8 mg
DRUG: Placebo

Sponsor

Pfizer